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Maria Auxiliadora Vieira do Carmo, Ricardo Alves Mesquita *Oral Surgery, Medicine and Pathology Department, Dentistry School, Federal University of Minas Gerais, Av. Antoˆnio
Carlos, 6627 sala 3204, Pampulha 31.270-901, Belo Horizonte, MG, BrazilReceived 5 December 2005; accepted 6 December 2005Summary Malignant peripheral nerve sheath tumour (MPNST) is a rare malignant neoplasm in
the maxillofacial region. This study reports on a sporadic case of MPNST located on the tongue
and provides a review of existing literature regarding this lesion. Data analyses show four well-
documented cases of MPNST on the tongue.c 2005 Elsevier Ltd. All rights reserved.
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3Introduction
Malignant peripheral nerve sheath tumour (MPNST) is the
coined term used by the World Health Organization and cor-
responds to the malignant proliferation of any cell of the
nerve sheath: Schawnn cell, perineural fibroblast or endo-
neural fibroblast.2,6 MPNST represents 5–10% of soft tissue
sarcomas and is manifested mainly associated to the type
I neurofibromatosis.2 About 8–16% MPNST develops in the
head and neck region.3 There are reports of only four spo-
radic cases involving the tongue in the English litera-
ture.6,8,9,12 The purpose of this paper is to report a case
of MPNST of the tongue occurring in a 37-year-old man
and to review the literature about this lesion.741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights reserved
oi:10.1016/j.ooe.2005.12.003
* Corresponding author. Tel.: +55 31 34992478; fax: +55 31
4992472.
E-mail address: ramesquita@ufmg.br (R.A. Mesquita).Case report
A 37 year-old black man was referred to the Oral Medicine
Clinic of the Federal University of Minas Gerais (UFMG), in
April 2004, complaining of swelling in the tongue with an
evolution of one week. The intraoral physical exam showed
a painful, ulcerated, exophitic, purple tumor measuring
2 · 2 cm in the posterior region of the tongue (Fig. 1(A)).
The clinical diagnoses were pyogenic granuloma and mesen-
quimal neoplasm. An incisional biopsy was taken and the
specimen fixed in 10% neutral formalin. Microscopic exami-
nation showed a solid neoplasm alternating within hyper and
hypocellular areas (Fig. 1(B)). The cells revealed spindle
form with wavy nuclei and elongated cytoplasmic process.
In focal area a Antoni A pattern was observed (Fig. 1(C)).
In the hypocellular area, representing a undifferentiated
area, the cells exhibited large and pleomorphic nuclei and
elongated cytoplasmic process (Fig. 1(D)). Foci of necrosis.
Figure 1 (A) An ulcerated, exophitic, purple tumor present in the posterior region of the tongue. (B) A solid neoplasm, with
hipercellular (left) and hipocellular areas (hematoxylin and eosin staining, X200). (C) In the hipercellular area, the cells were
arranged in Antoni A pattern (arrows) and revealed a spindle form with wavy nuclei and an elongated cytoplasmic process
(hematoxylin and eosin staining, X400). (D) The hipercellular area exhibited large and pleomorphic nuclei and an elongated
cytoplasmic process (hematoxylin and eosin staining, X400). (E) Neoplasic cells were S-100 positive (streptavidine–biotin technique,
X400). (F) Ki-67 showed to be positive in a few cells (streptavidine–biotin technique, X400). (G) No disease was observed over a 17
month period after surgery.
MPNST of the tongue 211and hemorrhaging were present. Immunohistochemical
reactions were performed with streptavidine–biotin proto-
col. The neoplasic cells were S-100 positive (Dako, clone:
Z0311, dilution 1:100, no antigen retrieval) (Fig. 1(E)).
Reactivity for Ki-67 (Dako, clone: A0047, dilution 1:75, anti-
gen retrieval with 0.01 M citric acid, 95 C, 30 min) was 6.1%
in hypercellular areas and 5.9% in hypocellular areas
(Fig. 1(F)). A diagnosis of MPNST was performed. The pa-
tient was re-evaluated; and type I neurofibromatosis was
discarded. The patient was treated using surgical resection
and still remains free-disease after seventeen months
(Fig. 1(G)).
A review of the English literature about MPNST of the
tongue that not associated with type I neurofibromatosis
demonstrated four well-documented cases over the last 29
years (Medline since 1966). Relevant data are presented in
Table 1.Discussion
MPNST is a rare malignant lesion, and the current case re-
port represents the fifth case located in the tongue. In the
maxillofacial region, MPNST can be found in the jaws or in
soft tissues. In soft tissues, the lesion usually appears with
indistinct margins, and may be ulcerated, painful or cause
paresthesia. This case report revealed an ulcerated andpainful lesion. Also, as the case reported, patients with
MPNST on the tongue are generally young.1,2,6,8–10,12
MPNST have arise ‘‘de novo’’ from a neuroectodermal
tissue, being considered a sporadic cases.2,3,8 This case rep-
resents a ‘‘de novo’’ form of the lesion, as it did not detect
any alteration or signs of type I neurofibromatosis. Histopa-
thologically, it was characterized as a conventional type
containing an area of schwannoma differentiation. The area
of schwannoma differentiation is present in 10% of
MPNST.2,4 Fifty to seventy percent of MPNST are S-100
immunopositive. Although S-100 expression is not exclusive
of MPNST, it is indicative of the neural differentiation.
Other proteins such as glial fibrillary acidic protein (GFAP),
Leu-7, myelin basic protein, neuron-specific enolase (NSE)
and neurofilament may be evaluated in the diagnosis of
the MPNST.5,7
The MPNST is treated by surgical excision, but local
recurrence is common. Hematogenous metastasis occurs
in at least half of all cases.2,3,8,9 The patient’s survival is
correlated to the size of the lesion, adequacy of margins,
association or not with type I neurofibromatosis, and immu-
nohistochemical findings. Watanabe et al.11 correlated a
high Ki-67 labeling index (>25%) with a reduced survival
rate. Our case had a Ki-67 labeling index below that of
25% in more differentiated and undifferentiated areas.
Overall, the five-year survival rate for MPNST is 40–75%.3
Follow-up on cases of MPNST of the tongue without type I
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212 A.M. Fernandes et al.neurofibromatosis (Table 1) ranged from one to three years,
with one case presenting metastase.6,8,9,12 The prognosis of
our patient is good, because it is a sporadic case, of small
size and was management with wide surgical excision.Acknowledgments
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